Work

Hiporfin photodynamic therapy for early-stage cervical cancer: A case report

Year: 2024

Type: article

Abstract: • This case report describes Hiporfin-PDT of a patient suffered from stage IA1 cervical cancer. • At 3 months post-PDT, cytology and HPV tests were negative, and at 6 months, biopsy pathology showed no lesions. • No signs of recurrence or HPV infection during the 12-month follow-up period. A 28-year-old female patient, diagnosed with stage IA1 cervical cancer, received PDT treatment with intravenous injection of Hiporfin, a HpD type photosensitizer. The patient's human papillomavirus (HPV) and cytology testing results were negative at the 3-month. At 6 months, the lesions on the cervical surface and within the cervical canal had completely resolved. There were no signs of recurrence or HPV infection during the 12-month follow-up period. There were no serious adverse events reported during or after the PDT treatment.

Source: Photodiagnosis and Photodynamic Therapy

DOI: 10.1016/j.pdpdt.2024.104422